Summary
-The new regulations will probably result in quality improvement in the selected targeted areas -It is unclear whether the cost of implementation and monitoring will offset the savings to the medicare system -Medicare will likely introduce further quality measures to fall under similar payment cuts.
Analysis
Nonpayment for poor performance will likely turn attention to the select list of clinical complications chosen by Medicare, but will likely introduce a whole new set of regulatory and monitoring hurdles which in the end will probably cost more than the intended savings.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
